The partners will provide testing through a program through which they also plan to establish a database of genetic test results and patient outcomes.
Researchers are using GenomeDx's database to improve understanding of the genomic underpinnings of prostate cancer and advance personalized treatment strategies.
The team has received around $900,000 in National Cancer Institute funding to develop new capabilities for CIVIC, improve curation, and engage with the community.
The institute announced ECRIgene this June, and is now offering it to paying subscribers from the clinical, regulatory, reimbursement, and test development spheres.
PNRI researchers will be able to analyze information from over 600,000 discrete tumor, blood, and urine samples from around 25,000 patients.
The grant from St. Baldrick's Foundation will be used to support UCSC's genomics and informatics Treehouse Childhood Cancer Initiative.
Responding to initial criticism of the draft guidelines on NGS testing, Mansfield emphasized that the documents are not final and assured that the agency will continue to listen to stakeholders.
The updated repository includes 265 drugs, 1,074 cell lines, as well as associated whole-exome sequencing and gene expression data among other datasets.
The agency has outlined a process for recognizing public genetic variant databases, but industry players say the field lacks incentives to advance such resources.
FDA's David Litwack said at the Festival of Genomics that the agency will soon release a draft document laying out a regulatory proposal for public comment.
Researchers uncovered the HIV virus within a tissue sample collected in 1966, the Atlantic reports.
Nature News reports there are a handful of clinical trials underway to evaluate vaginal microbiome seeding of newborns born via caesarian section.
The Washington Post writes that humans may have contributed to the extinction of cave bears some 20,000 years ago.
In PLOS this week: gene variant may protect against trypanosomiasis, GLIS3 role in type 2 diabetes, and more.